Blocklisting Six Monthly Retu

RNS Number : 8246X

Hutchison China Meditech Limited

30 June 2008

 



Hutchison China MediTech Limited ('Chi-Med')

(AIM: HCM)

Blocklisting Six Monthly Return

Date: Monday, 30 June 2008: Chi-Med announces the following blocklisting six monthly return: 

1.	Name of applicant:		Hutchison China MediTech Limited
2.	Name of scheme:		Hutchison China MediTech Limited Share Option Scheme
3.	Period of return:		From 27 December 2007 to 27 June 2008
4.	Balance under scheme from previous return:		2,543,553 ordinary shares of US$1 each
5.	The amount by which the block scheme has been increased, if the scheme has been increased since the date of the last return:		Nil
6.	Number of securities issued/allotted under scheme during period:		Nil
7.	Balance under scheme not yet issued/allotted at end of the period:		2,543,553 ordinary shares of US$1 each
8.	Number and class of securities originally listed and the date of admission:		2,560,606 ordinary shares of US$1 each admitted on 26 June 2007
9.	Total number of securities in issue at the end of the period:		51,229,174 ordinary shares of US$1 each.
Name of contact:			Christian Hogg
Address of contact:			21/F., Hutchison House, 10 Harcourt Road, Hong Kong
Telephone number of contact:			[phone]

Ends

Enquiries

Chi-Med   Christian Hogg, CEO	Telephone: [phone]
Citigate Dewe Rogerson   Anthony Carlisle    David Dible	Telephone: [phone] [phone] [phone]

About Chi-Med

Chi-Med is the holding company of a pharmaceutical and healthcare group focused on traditional Chinese medicine ('TCM') based primarily in China and was admitted to trading on the Alternative Investment Market of the London Stock Exchange in May 2006. Chi-Med operates three core business divisions: 1) China Healthcare - the manufacture, distribution and marketing of pharmaceuticals and health supplements in China; 2) Drug R&D - the discovery and global development of novel drug in the oncology and auto-immune therapeutic areas; and 3) Consumer Products - global retailing and distribution consumer health and personal care products derived from TCM and botanical ingredients.

Chi-Med is majority owned by Hutchison Whampoa Limited, an international company listed on the Main Board of The Stock Exchange of Hong Kong Limited.

 

END

 

 

BLRURSBRWBRNORR